Community psychiatry in Singapore: A pilot assertive community treatment (ACT) programme

Annals of the Academy of Medicine Singapore

Volumn 34, Issue 1, 2005, Pages 100-104

  Lim, Choon Guan ^a   Koh, C W ^a   Lee, C ^a   Poon, W C ^a  

^a INSTITUTE OF MENTAL HEALTH   (Singapore)

Author keywords

Assertive community treatment; Psychiatric rehabilitation; Schizophrenia

Indexed keywords

COST EFFECTIVENESS ANALYSIS; DISEASE COURSE; GROUP THERAPY; HEALTH PROGRAM; HUMAN; MENTAL DISEASE; MENTAL HEALTH; MENTAL HEALTH CARE; REVIEW; SCHIZOPHRENIA; SELF CARE; SINGAPORE; SOCIAL PSYCHIATRY;

EID: 15044364719     PISSN: 03044602     EISSN: 29724066     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Murray CJL, Lopez AD, editors. The Global Burden of Disease. Boston: Harvard Univ Press, 1996.
2. Thornicroft G, Tansella M. The Mental Health Matrix. A Manual to Improve Services. Cambridge: Cambridge Univ Press, 1999.
3. Thornicroft G, Szmukler G, editors. Textbook of Community Psychiatry. Oxford: Oxford Univ Press, 2001:253-63.
4. Tyrer P, Evans K, Gandhi N, Lamont A, Harrison-Read P, Johnson T. Randomised controlled trial of two models of care for discharged psychiatic patients. BMJ 1998;316:106-9.
5. Essock SM, Frisman LK, Kontos NJ. Cost-effectiveness of assertive community treatment teams. Am J Orthopsychiatry 1998;68:179-90.
6. Lim LE, Poo KP, Lein T, Chew SK. Why patients fail to attend psychiatric outpatient follow-up: a pilot study. Singapore Med J 1995;36:403-5.
7. McHorney CA, Ware JE, Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care 1994;32:40-66.
8. Sin J, Gamble C. Managing side-effects to the optimum: valuing a client's experience. J Psychiatr Ment Health Nurs 2003;10:147-53.
9. Loffler W, Kilian R, Toumi M, Angermeyer MC. Schizophrenic patients' subjective reasons for compliance and noncompliance with neuroleptic treatment. Pharmacopsychiatry 2003;36:105-12.
10. Weiss KA, Smith TE, Hull JW, Piper AC, Huppert JD. Predictors of risk of nonadherence in outpatients with schizophrenia and other psychotic disorders. Schizophr Bull 2002;28:341-9.
11. Cradock-O'Leary J, Young AS, Yano EM, Wang M, Lee ML. Use of general medical services by VA patients with psychiatric disorders. Psychiatr Serv 2002;53:874-8.
12. Subramaniam M, Chong SA, Pek E. Diabetes mellitus and impaired glucose tolerance in patients with schizophrenia. Can J Psychiatry 2003;48:345-7.
13. Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry 2002;63(Suppl 9):5-11. Erratum in: J Clin Psychiatry 2002;63:744
14. Davidson M. Risk of cardiovascular disease and sudden death in schizophrenia. J Clin Psychiatry 2002;63(Suppl 9):5-11. Erratum in: J Clin Psychiatry 2002;63:744
15. Chong SA, Choo HL. Smoking among Chinese patients with schizophrenia. Aust N Z J Psychiatry 1996;30:350-3.
16. Mueser KT, Bond GR, Drake RE, Resnick SG. Models of community care for severe mental illness: a review of research on case management. Schizophr Bull 1998;24:37-74.
17. Bond GR, McGrew JH, Fekete DM. Assertive outreach for frequent users of psychiatric hospitals: a meta-analysis. J Ment Health Adm 1995;22: 4-16.
18. Burns BJ, Santos AB. Assertive community treatment: an update of randomized trials. Psychiatr Serv 1995;46:669-75.
19. McGrew JH, Bond GR, Dietzen L, Salyers M. Measuring the fidelity of implementation of a mental health program model. J Consult Clin Psychol 1994;62:670-8.
20. Hambridge JA, Rosen A. Assertive community treatment for the seriously mentally Ill in suburban Sydney: a programme description and evaluation. Aust N Z J Psychiatry 1994;28:438-45.
21. Scott JE, Dixon LB. Assertive community treatment and case management for schizophrenia. Schizophr Bull 1995;21:657-68.
22. Hamann J, Leucht S, Kissling W. Shared decision making in psychiatry. Acta Psychiatr Scand 2003;107:403-9.